This course offers a comprehensive exploration of immuno-oncology, bridging foundational immunological principles with cutting-edge cancer immunotherapies. Designed for healthcare professionals, researchers, and advanced students, Immuno-Oncology Unlocked delves into the cellular and molecular mechanisms that drive immune responses against cancer, including antigen recognition, immune surveillance, and tumor immune evasion. Participants will gain in-depth knowledge of therapeutic strategies such as immune checkpoint inhibitors, CAR-T cell therapies, cancer vaccines, and tumor-infiltrating lymphocyte (TIL) therapy. The course also addresses key topics in clinical application, including biomarkers for patient selection, immune-related adverse events, and the integration of immunotherapy into standard oncology care. Through case studies, current clinical trial data, and expert-led discussions, learners will be equipped to critically evaluate and apply the latest advancements in the rapidly evolving field of cancer immunotherapy.
